UK dismisses Indian pathology outsourcing rumours
This article was originally published in Clinica
The British In Vitro Diagnostics Association (BIVDA) is downplaying the significance of a prominent story in the UK media regarding Department of Health plans to outsource pathology services to India - claims dismissed by the DoH as nonsense.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.